HNGE logo

Hinge Health Inc. Class A (HNGE)

$120.99

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on HNGE

Market cap

$9.83B

EPS

-12.34

P/E ratio

--

Price to sales

15.44

Dividend yield

--

Beta

1.176812

Price on HNGE

Previous close

$121.72

Today's open

$120.79

Day's range

$119.10 - $122.29

52 week range

$30.08 - $126.40

Profile about HNGE

CEO

--

Employees

1437

Headquarters

San Francisco, CA

Exchange

New York Stock Exchange

Shares outstanding

81271302

Issue type

Common Stock

HNGE industries and sectors

Healthcare

Healthcare Providers & Services

News on HNGE

Earnings Estimates Rising for Hinge Health Inc. (HNGE): Will It Gain?

Hinge Health Inc. (HNGE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

news source

Zacks Investment Research • Nov 9, 2026

news preview

Best Momentum Stocks to Buy for November 9th

TKO, HNGE and ECPG made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 9, 2026.

news source

Zacks Investment Research • Nov 9, 2026

news preview

What Hinge Health (HNGE) Said on Its Q3 Earnings Call

Hinge Health NYSE: HNGE reported third-quarter revenue growth of 52% year over year and raised its full-year outlook, as the digital musculoskeletal care company cited higher member engagement, client additions and improved operating leverage.

news source

MarketBeat • Nov 3, 2026

news preview

Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript

Hinge Health, Inc. (HNGE) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 3, 2026

news preview

Hinge Health reports record third quarter 2026 financial results

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update. “Our strong performance continues to reflect our ability to deliver exceptional clinical outcomes, a better healthcare experience and lower client costs at scale," said Daniel Perez, Co-Founder and CEO, Hinge Health. "This focus on the triple aim, via a technology platform that scales and automates care delivery, is also.

news source

Business Wire • Nov 2, 2026

news preview

Hinge Health Inc. (HNGE) Beats Q3 Earnings and Revenue Estimates

Hinge Health Inc. (HNGE) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.34 per share a year ago.

news source

Zacks Investment Research • Nov 3, 2026

news preview

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

HNGE's strong revenue growth, raised 2026 outlook and expansion into Migraine and GI care support its growth prospects despite investment pressures.

news source

Zacks Investment Research • Oct 29, 2026

news preview

Hinge Health to announce third quarter 2026 financial results on November 2, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) announced today that it will report its financial results for the quarter ended September 30, 2026, after the U.S. financial markets close on Monday, November 2, 2026. Hinge Health will also host an earnings conference call to discuss its results and guidance at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) the same day. The live audio webcast of the earnings conference call will be available on the Hinge Health Investor Relation.

news source

Business Wire • Oct 5, 2026

news preview

3 Healthcare Stocks Showing Why the Sector Still Has Momentum

The healthcare sector has performed fairly well so far in 2026 due to several factors: GLP-1 medications continue to drive new business and interest, while groundbreaking AI applications help enhance and accelerate the drug discovery process. On top of that, potential mergers and acquisitions activity, as big pharmaceutical companies face a major patent cliff, could provide opportunities for new firms to stand out.

news source

MarketBeat • Sep 28, 2026

news preview

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead

CNBC's Jim Cramer said investors should look beyond the AI data-center trade as compelling opportunities emerge in other areas of the market. He highlighted aerospace, fintech, health care and energy stocks.

news source

CNBC • Sep 8, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Hinge Health Inc. Class A

Open an M1 investment account to buy and sell Hinge Health Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in HNGE on M1